Tech Company Financing Transactions

MediQuest Therapeutics Funding Round

Integra Ventures and Novo Ventures participated in a $9.5 million funding round for MediQuest Therapeutics. The round was announced on 6/30/2006.

Transaction Overview

Announced On
6/30/2006
Transaction Type
Venture Equity
Amount
$9,500,000
Round
Undisclosed
Investors

Integra Ventures (Joseph Piper)

Novo Ventures (Søren Schifter)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
300 East Pine St.
Seattle, WA 98122
USA
Email Address
Overview
MediQuest Therapeutics, Inc. (MediQuest) is a specialty pharmaceutical company developing first- and best-in-class topical therapies in late-stage clinical development to treat patients suffering from inflammatory and infectious diseases.
Profile
MediQuest Therapeutics LinkedIn Company Profile
Social Media
MediQuest Therapeutics Company Twitter Account
Company News
MediQuest Therapeutics News
Facebook
MediQuest Therapeutics on Facebook
YouTube
MediQuest Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Frederick Dechow
  Frederick Dechow LinkedIn Profile  Frederick Dechow Twitter Account  Frederick Dechow News  Frederick Dechow on Facebook
Chief Financial Officer
Hans Lundin
  Hans Lundin LinkedIn Profile  Hans Lundin Twitter Account  Hans Lundin News  Hans Lundin on Facebook
Chief Medical Officer
Jeffrey Gregory
  Jeffrey Gregory LinkedIn Profile  Jeffrey Gregory Twitter Account  Jeffrey Gregory News  Jeffrey Gregory on Facebook
Chief Scientific Officer
Thomas Dooley
  Thomas Dooley LinkedIn Profile  Thomas Dooley Twitter Account  Thomas Dooley News  Thomas Dooley on Facebook
VP - Marketing
Tyler Ellison
  Tyler Ellison LinkedIn Profile  Tyler Ellison Twitter Account  Tyler Ellison News  Tyler Ellison on Facebook
VP - Regulatory Affairs
Carol Danielson
  Carol  Danielson LinkedIn Profile  Carol  Danielson Twitter Account  Carol  Danielson News  Carol  Danielson on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2006: Pyxant Labs venture capital transaction
Next: 6/30/2006: Linguagen venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary